Joost Leeflang Appointed New COCIR President

COCIRAt the COCIR General Assembly in Brussels, COCIR President Kevin Haydon announced that he would stand down from COCIR Presidency at the end of April 2015. Joost Leeflang has been elected as the new COCIR President and will represent Philips on the COCIR Board. Mr Leeflang has been with Philips for 20 years, holding positions in the Netherlands, Ukraine, Russia and as CEO in Central and Eastern Europe and was very recently appointed as Senior Vice President & Business Leader for Diagnostic Imaging.

Outgoing COCIR President Kevin Haydon thanked the COCIR membership and team for their excellent cooperation and work, saying "COCIR has successfully built a leading and united industry voice and is now recognised as an important industry stakeholder, sharing its competencies to build more sustainable healthcare system with access for safe, affordable healthcare for all European citizens."

On being appointed as new COCIR President at the COCIR General Assembly, Joost Leeflang said "I am happy to continue to capitalize on what COCIR has achieved. All COCIR industries have been working smartly together delivering highly innovative products and services. We are proud to have key global players based in Europe with important research and innovation investments that should be considered in EU policy making. Our industries have changed their business models providing integrated care approaches. They have successfully developed solutions critical to the transformation of our healthcare systems, to ensure these remain sustainable for generations to come."

COCIR Secretary General Nicole Denjoy expressed her thanks to Kevin Haydon for his strategic drive towards more recognition of our key healthcare technologies, saying "Kevin Haydon used his business insights to steer COCIR and to help build our presence in Europe and beyond. We wish him a wellearned retirement. I am looking forward to working with Joost Leeflang whose international business expertise will continue strengthening and guiding COCIR in the coming years."

About COCIR
COCIR is the European Trade Association representing the medical imaging, health ICT and electromedical industries. Founded in 1959, COCIR is a non-profit association headquartered in Brussels (Belgium) with a China Desk based in Beijing since 2007. COCIR is unique as it brings together the healthcare, IT and telecommunications industries.

Most Popular Now

AI also Assesses Dutch Mammograms Better…

AI is detecting tumors more often and earlier in the Dutch breast cancer screening program. Those tumors can then be treated at an earlier stage. This has been demonstrated by...

RSNA AI Challenge Models can Independent…

Algorithms submitted for an AI Challenge hosted by the Radiological Society of North America (RSNA) have shown excellent performance for detecting breast cancers on mammography images, increasing screening sensitivity while...

AI could Help Emergency Rooms Predict Ad…

Artificial intelligence (AI) can help emergency department (ED) teams better anticipate which patients will need hospital admission, hours earlier than is currently possible, according to a multi-hospital study by the...

Head-to-Head Against AI, Pharmacy Studen…

Students pursuing a Doctor of Pharmacy degree routinely take - and pass - rigorous exams to prove competency in several areas. Can ChatGPT accurately answer the same questions? A new...

NHS Active 10 Walking Tracker Users are …

Users of the NHS Active 10 app, designed to encourage people to become more active, immediately increased their amount of brisk and non-brisk walking upon using the app, according to...

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...